Form 4 for PCVX Vaxcyte, Inc.
Accepted 2025-01-22 00:00:00 ET · period of report 2025-01-21 · accession 0001649094-25-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-22 | 2025-01-21 | PCVX | GUGGENHIME ANDREW | Pres AND CFO | M - OptEx | $5.35 | +8,000 | 117.5K | +7% | +$42.8K |
| DM | 2025-01-22 | 2025-01-21 | PCVX | GUGGENHIME ANDREW | Pres AND CFO | S - Sale+OE | $86.51 | -8,000 | 109.5K | -7% | -$692.1K |
| D | 2025-01-22 | 2025-01-21 | PCVX | GUGGENHIME ANDREW | Pres AND CFO | M - OptEx | $0.00 | -8,000 | 254.8K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-21 | M | A | 8,000 | $5.35 | 117,491 | D | — | — | |
| 2 | Common | Common Stock | 2025-01-21 | S | D | 5,318 | $86.08 | 112,173 | D | — | — | (F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $85.54 to $86.455. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2025-01-21 | S | D | 1,999 | $87.25 | 110,174 | D | — | — | (F3) The price reported is a weighted-average price. The shares were sold at prices ranging from $86.58 to $87.545. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2025-01-21 | S | D | 683 | $87.70 | 109,491 | D | — | — | (F4) The price reported is a weighted-average price. The shares were sold at prices ranging from $87.58 to $87.85. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 5 | Derivative | Stock Option (right to buy) | 2025-01-21 | M | D | 8,000 | $0.00 | 254,827 | D | $5.35 · — to 2030-05-11 | 8,000 Common Stock | (F5) 1/4 of the shares subject to the option vested on May 1, 2021, and 1/48 of the shares vest monthly thereafter. |